Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An update on chronic obstructive pulmonary disease.

Roy A Pleasants1, Douglas Haden

  • 1Division of Pulmonary and Critical Care Medicine, Duke University School of Medicine, Durham, North Carolina, USA. roypleasants@duke.edu

The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
|March 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Randomized, Double-Blind Crossover Study of Change in Post-Dose Lung Function with Hydrofluoroolefin-1234ze, a Next-Generation Propellant for Metered Dose Inhalers, in Participants with Asthma.

Journal of aerosol medicine and pulmonary drug delivery·2025
Same author

The Epidemiology of Combined Pulmonary Fibrosis and Emphysema among Mid-Atlantic Veterans.

Annals of the American Thoracic Society·2025
Same author

Variability in chest radiology interpretation between thoracic and non-thoracic radiologists: Implications for pulmonary fibrosis care.

Respiratory medicine·2024
Same author

Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease.

Journal of aerosol medicine and pulmonary drug delivery·2024
Same author

Effect on Physical Position of Peak Inspiratory Flow in Stable COPD: An Observational Study.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2024
Same author

Current Perspectives of Pharmacotherapies for COPD.

Respiratory care·2023

This review updates chronic obstructive pulmonary disease (COPD) management based on new guidelines. Key interventions include early diagnosis, smoking cessation, and optimized medication use for better patient outcomes.

Area of Science:

  • Pulmonology
  • Pharmacology
  • Geriatrics

Background:

  • Chronic obstructive pulmonary disease (COPD) affects 5-7% of US adults, with higher prevalence in the elderly.
  • COPD is a progressive disease leading to significant health impairment.

Purpose of the Study:

  • To provide an update on the diagnosis and management of COPD.
  • To incorporate new international and national guidelines into clinical practice.

Main Methods:

  • Medline search for relevant articles.
  • Review of Global Initiative for Obstructive Lung Disease (GOLD) guidelines.
  • Review of American Thoracic Society/European Respiratory Society (ATS/ERS) COPD Guidelines.

Main Results:

Related Experiment Videos

  • New guidelines offer extensive insights into COPD management.
  • Key interventions include early diagnosis, pulmonary function testing, smoking cessation, and oxygen therapy.
  • Pharmacological management emphasizes bronchodilators and, in select cases, corticosteroids, alongside smoking cessation aids and supportive therapies.

    • Conclusions:

    • Pharmacists play a crucial role in optimizing drug selection and administration for COPD patients in long-term care.
    • Pharmacists can help prevent drug therapy complications, such as steroid-induced osteoporosis.